Palla Pharma Ltd
ASX:PAL

Watchlist Manager
Palla Pharma Ltd Logo
Palla Pharma Ltd
ASX:PAL
Watchlist
Price: 0.295 AUD Market Closed
Market Cap: AU$47.8m

Palla Pharma Ltd
Inventory

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Palla Pharma Ltd
Inventory Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
Palla Pharma Ltd
ASX:PAL
Inventory
AU$24.8m
CAGR 3-Years
7%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Genetic Technologies Ltd
ASX:GTG
Inventory
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Proteomics International Laboratories Ltd
ASX:PIQ
Inventory
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Trajan Group Holdings Ltd
ASX:TRJ
Inventory
AU$29.1m
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Cryosite Ltd
ASX:CTE
Inventory
AU$72k
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
-4%
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Inventory
AU$2.4m
CAGR 3-Years
98%
CAGR 5-Years
137%
CAGR 10-Years
N/A
No Stocks Found

Palla Pharma Ltd
Glance View

Palla Pharma Ltd. manufactures and produces narcotic raw material for the international pharmaceutical industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-13. The firm's primary activities include production and distribution of Narcotic Raw Material (NRM),Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The firm operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The firm has developed a water-based extraction technology, which is used in NRM production. The company sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.

PAL Intrinsic Value
Not Available

See Also

What is Palla Pharma Ltd's Inventory?
Inventory
24.8m AUD

Based on the financial report for Jun 30, 2021, Palla Pharma Ltd's Inventory amounts to 24.8m AUD.

What is Palla Pharma Ltd's Inventory growth rate?
Inventory CAGR 5Y
19%

Over the last year, the Inventory growth was -9%. The average annual Inventory growth rates for Palla Pharma Ltd have been 7% over the past three years , 19% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett